Facebook Twitter Linkedin NASDAQ Market NewsClick here to email authorNEXT STORYINNATE PHARMA RECEIVES PRIME DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR LACUTAMAB IN SÉZARY SYNDROMEPREV STORYAS COMMUNITY COVID-19 CASES RISE, RENOWN PREPARES